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Abstract
 Resistance to hormonal therapies is a major clinical problem
in the treatment of estrogen receptor α–positive (ERα+) breast
cancers 
 DNA methylation of cytosine at specific CpG sites are frequently associated
with ERα+ status in human breast cancers 
 Hypothesis : ERα may regulate gene expression via DNA methylation 3
Abstract
Evaluations : 
 Microarray gene expression profiling was used to identify genes normally silenced
in ERα cells but derepressed upon exposure to the demethylating agent
decitabine and resuppressed by gain of ERa activity/expression
 ERα dependent DNA methylation targets (n = 39) were enriched
for ERa-binding sites, basal-up/luminal-down markers, cancer
stem cell, epithelial–mesenchymal transition, and inflammatory and tumor 
suppressor genes
 Kaplan–Meier survival curve and Cox proportional hazards regression analyses 
indicated that these targets predicted poor distant metastasis–free survival(dmfs)
 The basal breast cancer subtype markers LCN2 and IFI27 showed the
greatest inverse relationship with ERα expression/activity
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implication
ERα directs DNA methylation–mediated silencing
of specific genes that have biomarker potential in breast cancer
subtypes 
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Introduction
ER(estrogen receptor 
Alpha)
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Presence of ERα lead to luminal 
classification
7
Breast 
cancer 
subtypes
Luminal 
A
Her2
enriched
Claudin 
lowBasal
like
Luminal 
B
Introduction
regulate gene expression
8
introduction
A functional link between ERα and DNA hypermethylation has
been demonstrated at the CYP1A1 locus, whose gene product 
converts 17β-estradiol (E2) into a metabolite that inhibits
proliferation; ERα silenced CYP1A1 by recruiting DNMT3B
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The relationship 
between ERα and 
cyp1a1
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To identify ERα targets CPG methylation mediated silencing by : 
1. genes upregulated by the demethylating agent decitabine
2. genes upregulated by loss of ERα expression in a series of
anti hormone -resistant T47D and MCF7 cell lines
3. Genes downregulated by E2 reexposure or increased ERα expression in
anti hormone-resistant T47D and MCF7 cells 
4. ER α for silencing
and DNA methylation of the basal breast cancer subtype markers
LCN2 and IFI27 in wild-type and anti hormone-resistant T47D based cell 
lines 
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Materials and methods 
• The fulvestrant (FUL)–resistant cell lines (T47D/FUL, MCF7/FUL)(in estrogenized 
media (RPMI1640 plus 10% whole FBS) supplemented with 100 nmol/L 
fulvestrant )
• the estrogen deprivation (ED)–resistant cell lines (T47D/ED1, T47D/ED2) ( in
estrogen-free media (phenol red-free RPMI1640 plus 10% dextran-coated charcoal-
stripped FBS )
were generated by continuous culture (8 weeks to >1 year) of wild-type
T47D and MCF-7 cells 
All authenticated by gene expression microarrays
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Materials and methods 
Cell lines
The lentiviral cell lines , T47D/ED1/VC, T47D/ED1/VC+E2,
T47D/ED1/ER α, and T47D/ED1/ER α +E2 were generated by
infecting ERα T47D/ED1 cells with an ER α -expressing lentivirus
or an empty vector control (VC) lentivirus 
Infected cells were maintained in estrogen-free or in 1 nmol/L
E2–supplemented medium for 12 weeks again 4 weeks later, infected 
cells were sorted for the lentiviral ZsGreen fluorescent marker using a 
Becton Dickinson cell sorter. 
To produce the lentiviral vectors, ER α 's coding region was excised 
from pHEGO using Eco RI and inserted into the Eco RI site of the 
lentiviral vector pLVX-EF1a-IRES-ZsGreen1 
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Materials and methods 
• RNA isolation
RNA was purified using Qiagen ‘s RNeasy Plus Kits 
• Real time pcr
using AMV First-Strand cDNA Kit,
TaqMan Universal PCR Master Mix,
and a 7900HT Fast Real-Time PCR system 
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Materials and methods 
Microarray
Genome-wide RNA profiling was carried out by the Genomics
Facility at Fox Chase Cancer Center (Philadelphia) using
Agilent's Human Gene Expression
Immunoblot analysis
Using RIPA buffer and 40 mg protein per lane 
Blots were visualized using the Odyssey Infrared Imaging System 
DNA methylation analysis by pyrosequencing 
Genomic DNA was isolated using the DNeasy Blood and Tissue
Kit (Qiagen) and treated with bisulfite
assayed the ratios of methylated cytosines to thymines
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Materials and methods 
Human breast cancer cohorts 
Breast cancer data from The Cancer Genome Atlas (TCGA) 
project were downloaded via the International Cancer Genome 
Consortium (ICGC) data portal 
Methylation data were retrieved for 1,013 patients, 967 of whom also had ERa status 
available. 
The gene expression microarray cohort comprising 2,116 breast
cancers was previously constructed 
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Materials and methods 
Metagenes
To analyze the composite expression level of gene sets in a
tumor, gene sets were represented as metagene
scores, or single number summary values were determined
the expression breast cancer cohort. 
These scores represent a expression values of each gene in the gene
set in individual tumors.
Metagene scores were generated by   "eigenvector" of
each gene set in each tumor using singular value decomposition
(SVD)
The eigenvector produced by SVD was rescaled to a 
score between 0 and 1, with 0 relating to the lowest composite
expression value for a gene set, and 1 relating to the highest
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RESULT
1. Identification of genes inversely correlated with ERα expression/activity 
2. Expression analysis of the candidate ER α DNA methylation gene set in breast 
cancer 
3. Inverse relationship between LCN2 and IFI27 expression and ER α
4. Direct relationship between methylation of LCN2 and IFI27 and ER α
5. LCN2 and IFI27 expression and CpG methylation in breast cancer cell lines
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Identification of genes inversely correlated with ERa
expression/activity 
To identify ERα targets for DNA methylation–mediated silencing 
1. those genes derepressed by loss of ER α expression
2. those genes resilenced by increased ERα activity or expression
3. those genes derepressed by loss  of DNA methylation. 
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Identification of genes inversely correlated with ERα
expression/activity 
1. as acute depletion of ERα in estrogen-dependent cells leads to widespread cell 
death 
2. microarrays 
3. ERα mRNA levels were measured by qRT-PCR 
4. Immunoblotting also demonstrated similar ERα protein losses 
5. starting with wild-type ERα+ T47D and MCF-7 luminal breast cancer cells, a panel 
of ERα-low/negative T47D and MCF7 breast cancer cells was in 100 nmol/L 
fulvestrant or in estrogen-free media for 8 weeks to greater than 1 year
6. T47D/ED1 cells lost 99.9%, T47D/FUL and T47D/ED2 cells
lost 95%, and MCF7/FUL cells (at week 8 of derivation) lost
90% of ERa mRNA compared with respective wild-type parental
cells 
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ERα mRNA level
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Microarray 
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ERα DNA Methylation
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DNA methylation and DMFS
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Inverse relationship between LCN2 and IFI27 
expression and ER α
 LCN2  and IFI27 contain ERα-binding sites Also both are
basal markers so LCN2 and IFI27 were selected for validation
of ERα-dependent changes in expression and 5mCpG levels.
 LCN2 mRNA and protein levels dramatically increased in a
time-dependent manner after precipitous drops in ERα levels
across all anti hormone-resistant models 
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Inverse relationship between LCN2 and IFI27 expression and ER α
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 Levels of selected 5mCpG sites near the TSSs of LCN2 and IFI27
were quantitated across the T47D-based models by pyrosequencing
 This analysis found LCN2 and IFI27 CpG sites to be significantly hypo methylated
in ERα negative T47D/FUL, T47D/ED1, and T47D/ED2 cells versus wild type 
ERα+ T47D cells and significantly hyper methylated upon E2 reexposure in 
T47D/ED2/E2 cells compared with parental T47D/ED2 cells 
 Therefore, LCN2 and IFI27 CpG  methylation levels directly associated with ERα
expression activity. 
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Direct relationship between methylation of LCN2 and IFI27 and ER α
Direct relationship between methylation of LCN2 and IFI27 and ER α
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Direct relationship between methylation of LCN2 and IFI27 and ER α
 ERα-T47D/ED1 cells were infected with an ERα-expressing lentivirus or an empty 
VC lentivirus generating T47D/ED1/ERa and T47D/ED1/VC cells
 These infected cells were maintained with and without E2 for 12 weeks and 
subjected to two rounds of cell sorting for the lentiviral ZsGreen fluorescent 
marker.
 Characterization of these lentiviral cells lines demonstrated ERα mRNAs were 
expressed at high levels in ERa infected cells. 
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LCN2 and IFI27 expression and CpG methylation in breast cancer cell lines
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discussion
• As ERα plays such a pivotal role in a more favorable outcome
in breast cancer, genes targeted by ERa for DNA methylation–
mediated silencing likely play important roles in disease progression 
•
Taken together, our data indicate that ERα can silence genes via
DNA methylation, such as LCN2 and IFI27. Moreover, ERα may
direct DNA methylation–mediated silencing of a subpopulation
of basal markers, CSC, and EMT genes that may potentially
enforce luminal differentiation of breast cancer cells. 
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Thanks for your attention32
